Literature DB >> 10904007

Differentiated long-term effects of intentional weight loss on diabetes and hypertension.

C D Sjöström1, M Peltonen, H Wedel, L Sjöström.   

Abstract

The beneficial effects of weight loss in the obese have been widely accepted. Still, there is a lack of controlled studies displaying large maintained weight losses over long periods (>4 years). We wanted to examine the results of long-standing intentional weight loss on the development of diabetes and hypertension in severely obese individuals over an 8-year period. In the ongoing prospective Swedish Obese Subjects (SOS) study, 346 patients awaiting gastric surgery were matched with 346 obese control subjects on 18 variables by a computerized matching program. The controls were drawn from a registry consisting of 1508 obese potential controls examined at primary health care centers in Sweden. Of the 692 selected patients (body mass index 41.2+/-4.7 kg/m(2) [mean+/-SD]), 483 (70%) were followed for 8 years. No significant weight changes occurred in the obese control group over 8 years. Gastric surgery resulted in a maximum weight loss of -31.1+/-13.6 kg after 1 year. After 8 years, the maintained weight loss was still 20.1+/-15.7 kg (16.3+/-12.3%). Whereas this weight reduction had a dramatic effect on the 8-year incidence of diabetes (odds ratio 0.16, 95% CI 0.07 to 0.36), it had no effect on the 8-year incidence of hypertension (odds ratio 1.01, 95% CI 0.61 to 1.67). A differentiated risk factor response was identified: a maintained weight reduction of 16% strongly counteracted the development of diabetes over 8 years but showed no long-term effect on the incidence of hypertension.

Entities:  

Mesh:

Year:  2000        PMID: 10904007     DOI: 10.1161/01.hyp.36.1.20

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  54 in total

1.  Long-term weight loss and changes in blood pressure.

Authors:  Arya M Sharma
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

2.  Impact of bariatric surgery on health care utilization and costs among patients with diabetes.

Authors:  Sara N Bleich; Hsien-Yen Chang; Bryan Lau; Kimberly Steele; Jeanne M Clark; Thomas Richards; Jonathan P Weiner; Albert W Wu; Jodi B Segal
Journal:  Med Care       Date:  2012-01       Impact factor: 2.983

3.  Willingness to pay as patient preference to bariatric surgery.

Authors:  Cristina Khawali; Marcos B Ferraz; Maria T Zanella; Sandra R G Ferreira
Journal:  Health Expect       Date:  2011-11-10       Impact factor: 3.377

Review 4.  New thoughts on managing obesity.

Authors:  P G Kopelman; C Grace
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

5.  The answer to diabetes prevention: science, surgery, service delivery, or social policy?

Authors:  Ruth Colagiuri; Stephen Colagiuri; Derek Yach; Stig Pramming
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

Review 6.  Surgery for morbid obesity.

Authors:  John M H Bennett; Samir Mehta; Michael Rhodes
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

7.  Interdisciplinary European guidelines for surgery for severe (morbid) obesity.

Authors:  Martin Fried; Vojtech Hainer; Arnaud Basdevant; Henry Buchwald; Mervyn Deitel; Nicholas Finer; Jan Willem M Greve; Fritz Horber; Elisabeth Mathus-Vliegen; Nicola Scopinaro; Rudolf Steffen; Constantine Tsigos; Rudolf Weiner; Kurt Widhalm
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

Review 8.  Weight reduction for treatment of obesity-associated hypertension: nuances and challenges.

Authors:  Allyn L Mark
Journal:  Curr Hypertens Rep       Date:  2007-11       Impact factor: 5.369

9.  Diet, Weight Loss, and Cardiovascular Disease Prevention.

Authors:  George A. Bray; Donna H. Ryan; David W. Harsha
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

10.  GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

Authors:  Camila Puzzi de Carvalho; Daniela Miguel Marin; Aglécio Luiz de Souza; José Carlos Pareja; Elintom Adami Chaim; Silvia de Barros Mazon; Conceição Aparecida da Silva; Bruno Geloneze; Elza Muscelli; Sarah Monte Alegre
Journal:  Obes Surg       Date:  2008-09-25       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.